Mostrar el registro sencillo del ítem
dc.contributor.author
Puricelli, Lydia Ines
dc.contributor.author
Bal, Elisa Dora
dc.contributor.author
Eiján, Ana María
dc.contributor.author
Entín, Daniel
dc.contributor.author
Sacerdote de Lustig, Eugenia
dc.date.available
2021-01-13T19:37:57Z
dc.date.issued
1985-11
dc.identifier.citation
Puricelli, Lydia Ines; Bal, Elisa Dora; Eiján, Ana María; Entín, Daniel; Sacerdote de Lustig, Eugenia; Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability; Elsevier; Cancer Letters; 29; 2; 11-1985; 189-195
dc.identifier.issn
0304-3835
dc.identifier.uri
http://hdl.handle.net/11336/122644
dc.description.abstract
The levels of fibronectin (FN) were assayed in plasma of mice subcutaneously inoculated with a mammary adenocarcinoma of moderate metastatic ability (M3) and a related variant tumor with higher metastasizing potential (MM3). The mean plasmatic FN concentration increased in parallel with increased M3 and MM3 size and weight. Highest and earliest FN increases were observed in mice inoculated with the rapidly growing M3 tumor. A strong correlation between the level of plasma fibronectin and the number of lung metastases was only found in MM3 inoculated mice. Plasma fibronectin level is a good biological marker of tumoral growth rate in these adenocarcinoma tumors, but its role in the metastatic process warrants investigation.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
FIBRONECTIN
dc.subject
ADENOCARCINOMA
dc.subject
SACERDOTE INVESTIGADORA
dc.subject
PUBLICACIONES
dc.subject.classification
Oncología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
dc.journal.volume
29
dc.journal.number
2
dc.journal.pagination
189-195
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Puricelli, Lydia Ines. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Bal, Elisa Dora. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Eiján, Ana María. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Entín, Daniel. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.journal.title
Cancer Letters
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/0304383585901582
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/0304-3835(85)90158-2
dc.provenance
Otro
dc.format.espacioDeColor
EscalaGris
dc.format.compresion
No especifica
dc.description.nivelDescripcion
Unidad documental simple
dc.type.subtype
Artículo científico
dc.type
info:ar-repo/semantics/artículo
Archivos asociados